ExceptionalTrackRecord2.85DVPIPfizerVenturesCorporateSpinoutsSyndicationPartnersTachiYamada,M.D.SundarKodiyalam$3.375BillionExitTop-tierInvestors150+Years’ExperienceARCHVenturePartnersAI &MachineLearningStrategicPartnershipsPennStateLeroyHood,M.D.,Ph.D.(BARDA)– onupdatedslide deckEmployeesAbbvieTargetedTherapeutic(Asset)FinancingMDAndersonCancerCenterPetraPharmaTurn-KeyFacilitiesRodeoTherapeuticsNeuroscience& NeurologyAcademic&ResearchInstitutionsApogenBiotechnologiesSteveGillis,Ph.D.$12.3MillionNIDAGrantUniformedServicesUniversityOperatingPartners?WeillCornellMedicineGeneYeo,Ph.D.EliLillyNon-DilutiveFunding1.02DPIMagnoliaNeurosciencesSanDiegoOfficeNewYorkOfficeSingaporeOfficeReviewed >4,000OpportunitiesBruceL.A.Carter,Ph.D.ColumbiaUniversityJanLundberg,Ph.D.OncologyUniversityofMinnesotaPronirasScientificExpertise$1 BillionGenentechCollaborationCPRITDiversityCSABMembers?WuXiPharmaTechUTSouthwesternMedicalCenterLodoTherapeuticsEntrepreneursCapital-efficiencyHarvardMedicalSchoolDanaFarberCancerLydianNeurosciencesGatesFoundation58.43%IRRTemasekDivestituresWRFCapitalAdvisory&CorporateBoardsTheRockefellerUniversityCaseWesternReserveAlexandriaVentureInvestments2014 Top-quartileRankedSubstantialExitHistorySeattleOfficeScientists&TechnologyDevelopersExceptionalTrackRecord2.85DVPIPfizerVenturesCorporateSpinoutsSyndicationPartnersTachiYamada,M.D.SundarKodiyalam$3.375BillionExitTop-tierInvestors150+Years’ExperienceARCHVenturePartnersAI &MachineLearningStrategicPartnershipsPennStateLeroyHood,M.D.,Ph.D.(BARDA)– onupdatedslide deckEmployeesAbbvieTargetedTherapeutic(Asset)FinancingMDAndersonCancerCenterPetraPharmaTurn-KeyFacilitiesRodeoTherapeuticsNeuroscience& NeurologyAcademic&ResearchInstitutionsApogenBiotechnologiesSteveGillis,Ph.D.$12.3MillionNIDAGrantUniformedServicesUniversityOperatingPartners?WeillCornellMedicineGeneYeo,Ph.D.EliLillyNon-DilutiveFunding1.02DPIMagnoliaNeurosciencesSanDiegoOfficeNewYorkOfficeSingaporeOfficeReviewed >4,000OpportunitiesBruceL.A.Carter,Ph.D.ColumbiaUniversityJanLundberg,Ph.D.OncologyUniversityofMinnesotaPronirasScientificExpertise$1 BillionGenentechCollaborationCPRITDiversityCSABMembers?WuXiPharmaTechUTSouthwesternMedicalCenterLodoTherapeuticsEntrepreneursCapital-efficiencyHarvardMedicalSchoolDanaFarberCancerLydianNeurosciencesGatesFoundation58.43%IRRTemasekDivestituresWRFCapitalAdvisory&CorporateBoardsTheRockefellerUniversityCaseWesternReserveAlexandriaVentureInvestments2014 Top-quartileRankedSubstantialExitHistorySeattleOfficeScientists&TechnologyDevelopers

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
I
2
B
3
I
4
G
5
N
6
O
7
B
8
G
9
B
10
B
11
O
12
G
13
G
14
N
15
O
16
B
17
I
18
I
19
O
20
I
21
N
22
G
23
O
24
N
25
B
26
G
27
G
28
O
29
G
30
I
31
B
32
I
33
G
34
O
35
O
36
I
37
B
38
G
39
N
40
B
41
N
42
O
43
G
44
I
45
B
46
B
47
N
48
O
49
N
50
N
51
B
52
G
53
G
54
I
55
I
56
B
57
N
58
I
59
N
60
B
61
G
62
O
63
O
64
N
65
I
66
N
67
I
68
B
69
O
70
I
71
O
72
N
  1. I-Exceptional Track Record
  2. B-2.85 DVPI
  3. I-Pfizer Ventures
  4. G-Corporate Spinouts
  5. N-Syndication Partners
  6. O-Tachi Yamada, M.D.
  7. B-Sundar Kodiyalam
  8. G-$3.375 Billion Exit
  9. B-Top-tier Investors
  10. B-150+ Years’ Experience
  11. O-ARCH Venture Partners
  12. G-AI & Machine Learning
  13. G-Strategic Partnerships
  14. N-Penn State
  15. O-Leroy Hood, M.D., Ph.D.
  16. B-(BARDA) – on updated slide deck
  17. I-Employees
  18. I-Abbvie
  19. O-Targeted Therapeutic (Asset) Financing
  20. I-MD Anderson Cancer Center
  21. N-Petra Pharma
  22. G-Turn-Key Facilities
  23. O-Rodeo Therapeutics
  24. N-Neuroscience & Neurology
  25. B-Academic & Research Institutions
  26. G-Apogen Biotechnologies
  27. G-Steve Gillis, Ph.D.
  28. O-$12.3 Million NIDA Grant
  29. G-Uniformed Services University
  30. I-Operating Partners?
  31. B-Weill Cornell Medicine
  32. I-Gene Yeo, Ph.D.
  33. G-Eli Lilly
  34. O-Non-Dilutive Funding
  35. O-1.02 DPI
  36. I-Magnolia Neurosciences
  37. B-San Diego Office
  38. G-New York Office
  39. N-Singapore Office
  40. B-Reviewed > 4,000 Opportunities
  41. N-Bruce L.A. Carter, Ph.D.
  42. O-Columbia University
  43. G-Jan Lundberg, Ph.D.
  44. I-Oncology
  45. B-University of Minnesota
  46. B-Proniras
  47. N-Scientific Expertise
  48. O-$1 Billion Genentech Collaboration
  49. N-CPRIT
  50. N-Diversity
  51. B-CSAB Members?
  52. G-WuXi PharmaTech
  53. G-UT Southwestern Medical Center
  54. I-Lodo Therapeutics
  55. I-Entrepreneurs
  56. B-Capital-efficiency
  57. N-Harvard Medical School
  58. I-Dana Farber Cancer
  59. N-Lydian Neurosciences
  60. B-Gates Foundation
  61. G-58.43% IRR
  62. O-Temasek
  63. O-Divestitures
  64. N-WRF Capital
  65. I-Advisory & Corporate Boards
  66. N-The Rockefeller University
  67. I-Case Western Reserve
  68. B-Alexandria Venture Investments
  69. O-2014 Top-quartile Ranked
  70. I-Substantial Exit History
  71. O-Seattle Office
  72. N-Scientists & Technology Developers